152 related articles for article (PubMed ID: 12826170)
1. De novo tumors after kidney transplantation: the Budapest experience.
Langer RM; Járay J; Tóth A; Hídvégi M; Végsö G; Perner F
Transplant Proc; 2003 Jun; 35(4):1396-8. PubMed ID: 12826170
[TBL] [Abstract][Full Text] [Related]
2. Impact of cyclosporine versus tacrolimus on the incidence of de novo malignancy following liver transplantation: a single center experience with 609 patients.
Wimmer CD; Angele MK; Schwarz B; Pratschke S; Rentsch M; Khandoga A; Guba M; Jauch KW; Bruns C; Graeb C
Transpl Int; 2013 Oct; 26(10):999-1006. PubMed ID: 23952102
[TBL] [Abstract][Full Text] [Related]
3. Are heart transplant recipients more likely to develop skin cancer than kidney transplant recipients?
Gjersvik P; Hansen S; Møller B; Leivestad T; Geiran O; Simonsen S; Pfeffer P; Fauchald P
Transpl Int; 2000; 13 Suppl 1():S380-1. PubMed ID: 11112037
[TBL] [Abstract][Full Text] [Related]
4. Study of "de novo" malignancies among greek renal transplant recipients.
Zavos G; Bokos J; Papaconstantinou J; Boletis J; Gazouli M; Pappas P; Kostakis A
Transplant Proc; 2003 Jun; 35(4):1399-403. PubMed ID: 12826171
[TBL] [Abstract][Full Text] [Related]
5. High incidence of posttransplant diabetes mellitus in renal transplant recipients on triple-drug immunosuppression.
Sakhuja V; Sharma UK; Jha V; Minz M; Chugh KS
Transplant Proc; 1995 Oct; 27(5):2728-30. PubMed ID: 7482892
[No Abstract] [Full Text] [Related]
6. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
7. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
8. Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.
Sampaio MS; Cho YW; Shah T; Bunnapradist S; Hutchinson IV
Transplantation; 2012 Jan; 93(1):73-81. PubMed ID: 22129761
[TBL] [Abstract][Full Text] [Related]
9. Early de novo malignancies after kidney transplantation.
Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of posttransplantation malignancies compared with de novo tumors.
Haberal AN; Süren D; Demirhan B; Bilezikçi B; Celasun B; Haberal M
Transplant Proc; 2007 May; 39(4):1057-62. PubMed ID: 17524891
[TBL] [Abstract][Full Text] [Related]
11. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
[TBL] [Abstract][Full Text] [Related]
12. Successful conversion from cyclosporine to azathioprine in elective renal transplant recipients.
Chuang FR; Hsieh H; Hsu KT; Chien YS; Chung HM
Transplant Proc; 1998 Nov; 30(7):3094-6. PubMed ID: 9838365
[No Abstract] [Full Text] [Related]
13. Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Opelz G; Döhler B;
Transplantation; 2009 Mar; 87(6):795-802. PubMed ID: 19300179
[TBL] [Abstract][Full Text] [Related]
14. [Early de novo neoplasia after renal transplantation].
Veroux P; Veroux M; Puliatti C; Amodeo C; Macarone M; Cappello D; Caglià P
Tumori; 2003; 89(4 Suppl):301-4. PubMed ID: 12903627
[TBL] [Abstract][Full Text] [Related]
15. Infectious complications in renal transplant recipients: a 10-year review of cyclosporine-based immunosuppression.
Tsai MK; Lee PH; Hu RH; Lee CJ
Transplant Proc; 1998 Nov; 30(7):3125-6. PubMed ID: 9838381
[No Abstract] [Full Text] [Related]
16. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
17. [De novo neoplasms in transplant patients].
Careaga-Reyna G; Argüero-Sánchez R
Gac Med Mex; 1999; 135(1):1-4. PubMed ID: 10204306
[TBL] [Abstract][Full Text] [Related]
18. Non-lymphoid cancer after liver transplantation.
Frezza EE; Fung JJ; van Thiel DH
Hepatogastroenterology; 1997; 44(16):1172-81. PubMed ID: 9261620
[TBL] [Abstract][Full Text] [Related]
19. Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation.
Cherikh WS; Kauffman HM; McBride MA; Maghirang J; Swinnen LJ; Hanto DW
Transplantation; 2003 Nov; 76(9):1289-93. PubMed ID: 14627905
[TBL] [Abstract][Full Text] [Related]
20. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
